SCA Pharmaceuticals, LLC

SCA Pharmaceuticals Recalls PHENYLephrine HCl Injection Due to Sterility Concerns, Impacting US Supply Chains

SCA Pharmaceuticals initiated a Class II recall for 8,050 syringes of PHENYLephrine HCl Injection from its Windsor, CT facility, citing lack of sterility assurance. This nationwide action, now terminated, underscores critical quality control vulnerabilities in sterile drug manufacturing. Procurement and regulatory teams must scrutinize supplier quality systems to mitigate similar supply disruptions and patient safety risks.